Skip to content

Conservative versus Arthroplasty for Nondisplaced Femoral Neck Fracture: An Open-label, Randomized, Multicenter clinical Trial

Conservative versus Arthroplasty for Nondisplaced Femoral Neck Fracture: An Open-label, Randomized, Multicenter clinical Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105731
Enrollment
Unknown
Registered
2025-07-09
Start date
2024-05-02
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Interventions

Experimental Group:Conservative management, including standardized pharmacological therapy and rehabilitation training. If conservative treatment fails, patients may transition to surgical interventio
Control group:Conservative management, including standardized pharmacological therapy and rehabilitation training. If conservative treatment fails, patients may transition to surgical intervention dur

Sponsors

Shanghai Sixth People's Hospital Affiliated to Shanghai JiaoTong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 60 years. 2. Hip X-ray showing unilateral Garden type I or II femoral neck fractures (including valgus impacted fractures) with a posterior tilt angle < 20 degrees. 3. The patient is willing to undergo surgical treatment.

Exclusion criteria

Exclusion criteria: 1. Garden type III-IV femoral neck fractures. 2. Posterior tilt angle = 20 degrees. 3. X-ray indicates that pathological fractures cannot be excluded (including tumors, stress fractures, fragility fractures, etc.). 4. Combined fractures in other parts of the lower limb. 5. Bilateral hip joints have undergone previous surgical interventions. 6. Presence of other joint-related diseases, such as systemic or inflammatory joint diseases (e.g., rheumatoid arthritis), a history of crystal-induced or neuropathic arthropathy, or other muscle, joint, or nervous system disorders affecting lower limb function, as well as metabolic bone diseases. 7. Immunosuppression or acute infections. 8. Patients with allergies to treatments involved in the study. 9. Current or past malignancy. 10. Presence of bleeding disorders or ongoing anticoagulant or antiplatelet therapy. 11. Pregnancy. 12. Body Mass Index (BMI) > 40 kg/m^2. 13. Inability to attend all scheduled study appointments within 12 months. 14. Inability to understand written and spoken Chinese. 15. History of any psychiatric or psychological disorders.

Design outcomes

Primary

MeasureTime frame
EQ-5D-5L;

Secondary

MeasureTime frame
Incidence OF COMPLICATIONS;The Timed Up and Go;OHS score;WOMAC score;mortality;

Countries

China

Contacts

Public ContactChangqing zhang; Weitao Jia

Shanghai Sixth People's Hospital Affiliated to Shanghai JiaoTong University

bonesjtubyq@163.com+86 18 651 490 9988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026